SCHEMBL1782691

SCHEMBL1782691

Cc1ccc(SSc2ccc(C)cc2-c2ccccc2C)c(-c2ccccc2C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.44
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
HPGD P15428 2/20 0.40
ALOX15 P16050 2/20 0.40
KMT2A Q03164 2/20 0.40
USP2 O75604 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.36
CYP2A6 P11509 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 2/20 0.35
CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1784408 0.88 ELANE (0.44) ELANENPC1RAB9AMEN1HPGD
SCHEMBL944302 0.81 TSHR (0.43) NPC1RAB9AMEN1HPGDKMT2A
SCHEMBL277747 0.81 ELANE (0.52) ELANENPC1RAB9AMEN1HPGD
SCHEMBL14816308 0.78 MAOA (0.49) ELANENPC1RAB9AHPGDCYP2A6
SCHEMBL575883 0.78 HDAC7 (0.46) ELANENPC1RAB9AMEN1HPGD
SCHEMBL29590360 0.76 ELANE (0.52) ELANENPC1RAB9AMEN1HPGD
SCHEMBL11729295 0.76 ELANE (0.52) ELANENPC1RAB9AMEN1HPGD
SCHEMBL16768825 0.75 HTR1A (0.45) NPC1RAB9AMAPTTP53CYP2A6
SCHEMBL15430420 0.73 HPGD (0.59) ELANENPC1RAB9AMEN1HPGD
SCHEMBL31746199 0.73 HPGD (0.59) ELANENPC1RAB9AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323975-B1 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES SI GROUP INC (US) 2019-04-24 EP disclosed
US-20110124540-A1 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES ALBEMARLE CORPORATION (US) 2011-05-26 US disclosed
EP-2323975-A2 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES Albemarle Corporation (US) 2011-05-25 EP disclosed
WO-2010011523-A2 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES ALBEMARLE CORPORATION (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124540-A1 MULTI-RING ANTIOXIDANTS WITH ANTIWEAR PROPERTIES GSR, CBR1, SOD1 ELANE 2215/4885NPC1 2328/4885RAB9A 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.